← Back to Search

Telemedicine Referral for Childhood Hearing Loss

N/A

Recruiting

Led By Denise Dillard, PhD

Research Sponsored by University of Arkansas

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up proportion of children who receive follow-up will be measured by the occurrence of an ear/hearing encounter, up to 60 days from the date of screening.

Awards & highlights

No Placebo-Only Group

Summary

This trial will test whether a new telemedicine intervention called STAR can reduce loss to follow-up in rural Alaska after school hearing screenings. It will compare the intervention to the standard referral of a letter home to families, and evaluate over three academic years.

Who is the study for?

This trial is for children in grades K-12 attending participating schools in rural Alaska regions. It aims to address high rates of childhood hearing loss, which is often preventable and related to infections.

What is being tested?

The study compares two methods: the standard referral process versus a telemedicine intervention called STAR, which brings specialty care directly into schools after mobile health screenings.

What are the potential side effects?

Since this trial involves screening and referral processes rather than medical treatments or drugs, there are no direct side effects associated with the interventions being tested.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ proportion of children who receive follow-up will be measured by the occurrence of an ear/hearing encounter, up to 60 days from the date of screening.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~proportion of children who receive follow-up will be measured by the occurrence of an ear/hearing encounter, up to 60 days from the date of screening.

This trial's timeline: 3 weeks for screening, Varies for treatment, and proportion of children who receive follow-up will be measured by the occurrence of an ear/hearing encounter, up to 60 days from the date of screening. for reporting.